Home › FDA OKs Merck hepatitis C drug, adding to patient choices
 

Keywords :   


FDA OKs Merck hepatitis C drug, adding to patient choices

2016-01-29 02:48:54| Biotech - Topix.net

Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing Zepatier for patients with two of the subtypes the liver-destroying virus, types 1 and 4. The combination pill includes the medications elbasvir and grazoprevir, which attack the virus in two different ways.

Tags: drug adding patient choices

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 22
08.11Hurricane Rafael Forecast Advisory Number 22
08.11Hurricane Rafael Public Advisory Number 22
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Trump tariffs could cost UK 22bn of exports
08.11Watchdog to review police handling of Al Fayed abuse claims
08.11Cattle marketing: Its about making the right decisions
More »